Minireview: The year in obesity and cancer

Molecular Endocrinology

Volumn 26, Issue 12, 2012, Pages 1961-1966

  Hursting, Stephen D ^a,b  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; CYTOKINE; EVEROLIMUS; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN; METFORMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOMATOMEDIN C; TRIACYLGLYCEROL; VASCULOTROPIN; WNT1 PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CALORIC INTAKE; CALORIC RESTRICTION; CANCER CELL; CANCER INCIDENCE; CANCER PREVENTION; CANCER RESEARCH; CELL STRUCTURE; CELL SURVIVAL; DYSLIPIDEMIA; ENERGY BALANCE; ENERGY EXPENDITURE; EXERCISE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; LOW CARBOHYDRATE DIET; MEDICAL SOCIETY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE PHOSPHORYLATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCIENTIFIC LITERATURE; SIGNAL TRANSDUCTION; TREATMENT RESPONSE; TUMOR GROWTH; WAIST CIRCUMFERENCE;

ANIMALS; CYTOKINES; DIABETES MELLITUS; HUMANS; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; OBESITY;

EID: 84870329450     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1283     Document Type: Article

References (21)

1. Flegal KM, Carroll MD, Kit BK, Ogden CL 2012 Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 307:491-497
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ 2003 Overweight, obesity, and mortality from cancer in a prospective studied cohort of U. S. adults. N Engl J Med 348:1625-1638
3. Colditz GA, Wollin KY, Gehlert S 2012 Applying what we know to accelerate cancer prevention. Sci Transl Med 127:1-9
4. Hanahan D, Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144:646-674
5. Hursting SD, Hursting MJ 2012 Growth signals, inflammation and vascular perturbations: mechanistic links between obesity, metabolic syndrome and cancer. Arterioscler Thromb Vasc Biol 32: 1766-1770
6. Willette AA, Bendlin BB, Colman RJ, Kastman EK, Field AS, Alexander AL, Sridharan A, Allison DB, Anderson R, Voytko ML, Kemnitz JW, Weindruch RH, Johnson SC 2012 Calorie restriction reduces the influence of glucoregulaltory dysfunction on regional brain volume in aged rhesus monkeys. Diabetes 61:1036-1042
7. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN 2010 Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 31:83-89
8. Nogueira LM, Dunlap SM, Ford NA, Hursting SD 2012 Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity. Endocr Relat Cancer 19:57-68
9. DeAngel RE, Conti CJ, Wheatley KE, Brenner AJ, deGraffenried LA, Hursting SD 30 January 2012 The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by Rad001. Mol Carcinog 10.1002/mc.21878
10. Pollak M 2012 Metformin and pancreatic cancer: a clue requiring investigation. Clin Cancer Res 18:2723-2725
11. Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A 2012 Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 72:2314-2326
12. Currie CJ, Poole CD, Gale EA 2009 The influence of glucose-lowering therapies on cancer risk in type 2 diabetics. Diabetologia 52:1766-1777
13. Currie CJ, Poole CD, Jenkins-Jones S, Gale EA, Johnson JA, Morgan CL 2012 Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 35:299-304
14. Dowling RJ, Niraula S, Stambolic V, Goodwin PJ 2012 Metformin in cancer: translational challenges. J Mol Endocrinol 48:R31-R43
15. Subbaramaiah K, Howe LR, Bhardway P, Du B, Gravaghi C, Yantiss RK, Zhou XK, Blaho VA, Hia T, Yang P, Kopelovich L, Hudis CA, Dannenberg AJ 2011 Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 4:329-346
16. Hursting SD, DiGiovanni J, Dannenberg AJ, Azrad M, LeRoith D, Demark-Wahnefried W, Kakarala M, Brodie A, Berger NA 27 September 2012 Obesity, energy balance and cancer: new opportunities for prevention. Cancer Prev Res 10.1158/1940-6207. CAPR-12-1040
17. Ward PS, Thompson CB 2012 Metabolic reprogramming: a cancer hallmark even Warburg did not anticpate. Cancer Cell 21:297-308
18. Pollak M 2012 The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer 12:159-169
19. Locasale JW, Cantley LC 2011 Metabolic flux and the regulation of mammalian cell growth. Cell Metab 14:443-451
20. Harvie M, Howell A 2012 Energy restriction and the prevention of breast cancer. Proc Nutr Soc 71:263-275
21. Dunlap SM, Chiao LJ, Nogueira L, Usary J, Perou CM, Varticovski L, Hursting SD 2012 Obesity enhances epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basallike mammary tumor models. Cancer Prev Res 5:930-942